Steven F. Bellon - 11 Aug 2022 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role: Chief Scientific Officer
Signature: /s /Allan Reine, M.D., Attorney-in-Fact
Issuer symbol: FHTX
Transactions as of: 11 Aug 2022
Net transactions value: +$6,912
Form type: 4
Filing time: 15 Aug 2022, 18:15:12 UTC
Previous filing: 27 May 2022
Next filing: 30 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FHTX	Common Stock	Options Exercise	$6,912	+1,858	+1.5%	$3.72	121,957	11 Aug 2022	Direct
holding	FHTX	Common Stock						50,000	11 Aug 2022	See Footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FHTX	Stock Options (Right to buy)	Options Exercise	$0	-1,858	-33%	$0.000000	3,716	11 Aug 2022	Common Stock	1,858	$3.72	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held by the Steven F. Bellon 2021 Irrevocable Trust dated December 3, 2021, of which the Reporting Person's children are the trustees.
F2	The option vested as to 25% of the underlying shares of common stock on January 30, 2020, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.